HAP Trading’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,034,300
Closed -$16.6M 1649
2019
Q4
$16.6M Buy
1,034,300
+313,800
+44% +$20.9M 0.91% 20
2019
Q3
$3.4M Buy
720,500
+583,300
+425% +$23.3M 0.28% 67
2019
Q2
$1.11M Sell
137,200
-337,300
-71% -$11M 0.09% 198
2019
Q1
$2.87M Buy
+474,500
New +$11.2M 0.26% 79
2017
Q2
Sell
-93,800
Closed -$216K 1251
2017
Q1
$216K Buy
93,800
+81,000
+633% +$3.69M 0.01% 467
2016
Q4
$18K Buy
+12,800
New +$454K ﹤0.01% 786
2016
Q3
Sell
-30,100
Closed -$37K 1282
2016
Q2
$37K Buy
+30,100
New +$1.06M ﹤0.01% 645
2015
Q3
Sell
-40,000
Closed -$11K 1247
2015
Q2
$11K Hold
40,000
﹤0.01% 845
2015
Q1
$59K Buy
+40,000
New +$1.12M ﹤0.01% 604

Other funds holding MDCO

HAP Trading's MDCO Position: Q1 2020 in Review

HAP Trading sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 56,257 shares — an estimated $4.78M sold.

HAP Trading first reported a position in MDCO in Q1 2015 and held it in 7 quarters. The position peaked at $4.78M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • HAP Trading reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • HAP Trading sold 56,257 Medicines Co shares in Q1 2020, an estimated $4.78M.
  • HAP Trading first reported a position in Medicines Co in Q1 2015 and held it in 7 quarters.
  • HAP Trading's Medicines Co position peaked at $4.78M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on HAP Trading's 13F filing for Q1 2020, filed 8 May 2020.